Glaukos Corporation

This study is testing whether adding a slow-release drug implant works better than a drainage device alone for controlling eye pressure in glaucoma. About 230 adults with glaucoma will receive either the combination treatment or just the drainage device, then be followed for one …

This study is testing a small, dissolvable implant placed inside the eye to slowly release medication for glaucoma. It aims to control eye pressure more conveniently than daily eye drops. The trial will compare the implant's safety and effectiveness against standard eye drop trea…

This study is testing a new medication called GLK-321 for people with Demodex blepharitis, a common eyelid condition caused by tiny mites. About 250 participants will be randomly assigned to receive either the active treatment or a placebo eye drop for 6 weeks. The main goal is t…

This study is testing whether a new eye drop called GLK-221 can safely slow or improve the corneal bulging caused by keratoconus. About 100 adults with keratoconus will use the drops or a placebo twice daily. Researchers will measure changes in the shape of the cornea to see if t…

This study is testing if adding a tiny, slow-release drug implant during routine cataract surgery can safely lower eye pressure in people who also have glaucoma or high eye pressure. The implant is designed to release medication over time. Researchers will compare results from pa…

This study is testing an updated tool used by doctors to place a tiny, long-acting implant in the eye for glaucoma. The implant slowly releases medication to help control high eye pressure. Researchers will observe 30 adult patients with open-angle glaucoma to see how well the ne…

This study is testing a small, long-lasting implant placed inside the eye to lower eye pressure for people with glaucoma. It aims to see if this single implant works as well as or better than using prescription eye drops twice a day. The goal is to provide a new, convenient optio…